NAKANO Isao

写真a

Affiliation Department etc.

Department of Materials Science and Engineering
Health Support Center

Title

Professor

Graduating School

  •  
    -
    1984.03

    Nagoya University   Faculty of Medicine   Graduated

Degree

  • Nagoya University -  Doctor of Medicine

Field of expertise (Grants-in-aid for Scientific Research classification)

  • Gastroenterology

  • Hygiene and public health

 

Research Career

  • Develepment of vaccine against hepatitis C vcrius

    Individual   (not selected)  

    Project Year:   - 

Papers

  • Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment.

    Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H.

    Oncology   95 ( 2 ) 91 - 99   2018.05  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93.

    Ishigami M, Hayashi K, Honda T, Kuzuya T, Ishizu Y, Ishikawa T, Urano F, Kumada T, Yoshioka K, Hirooka Y, Goto H.

    Jounal of Medical Virolology.   90 ( 4 ) 736 - 744   2017.12  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment.

    Ando Y, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H.

    Hepatology Research   48 ( 3 ) 240 - 251   2017.09  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction.

    Ishigami M, Hayashi K, Honda T, Kuzuya T, Ishizu Y, Ishikawa T, Nakano I, Urano F, Kumada T, Yoshioka K, Goto H, Hirooka Y.

    Clinical Gastroenterology and Hepatology   15 ( 5 ) 787 - 788   2017.05  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.

    Honda T, Ishigami M, Luo F, Lingyun M, Ishizu Y, Kuzuya T, Hayashi K, Ishikawa T, Feng GG, Katano Y, Kohama T, Kitaura Y, Shimomura Y, Goto H, Hirooka Y

    Metabolism   69   177 - 187   2017.01  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma.

    Kuzuya T1, Ishigami M, Ishizu Y, Honda T, Hayashi K, Ishikawa T, Nakano I, Goto H, Hirooka Y.

    Onclogy     2016.09  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Immunoglobulin G4-associated autoimmune hepatitis later complicated by autoimmune pancreatitis: A case report.

    Ishizu Y, Ishigami M, Kuzuya T, Honda T, Hayashi K, Nakano I, Hirooka Y, Goto H.

    Hepatol Res     2015.10  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Early Clinical Response after 2 Weeks of Sorafenib Therapy Predicts Outcomes and Anti-Tumor Response in Patients with Advanced Hepatocellular Carcinoma.

    Kuzuya T, Ishigami M, Ishizu Y, Honda T, Hayashi K, Katano Y, Hirooka Y, Ishikawa T, Nakano I, Goto H

    PLoS One.     2015.09  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

    Honda T1, Ishigami M, Masuda H, Ishizu Y, Kuzuya T, Hayashi K, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Urano F, Yoshioka K, Toyoda H, Kumada T, Katano Y, Goto H.

    J Gastroenterol Hepatol.     2015.02  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

  • Hepatitis B e antigen and hepatitis B surface antigen seroclearance with the emergence of lamivudine-associated and core mutations following CD4 elevation in a patient with hepatitis B and HIV.

    Honda T1, Ishigami M, Luo F, Ishizu Y, Kuzuya T, Hayashi K, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Katano Y, Goto H.

    Intern Med.     2015.01  [Refereed]

    Research paper (scientific journal)   Multiple Authorship

display all >>

Books

  • AIDS handbook 2013

    (Part: Multiple Authorship )

    2013.03 ISBN: 978-4-907747-32-9